DBV Technologies DBVT
NASDAQ DBVT
$11.55 -0.09 (-0.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

DBV Technologies (DBVT) Common Equity (2015 - 2026)

Updated

DBV Technologies (DBVT) posted Common Equity of $160.4 million for Q2 2026, up 86.1% from $86.2 million a year earlier but down 22.8% from the prior quarter.

Analysis

DBV Technologies (DBVT) Common Equity (2015 - 2026) Analysis & Trends

At the end of FY2025, DBV Technologies' Common Equity came in at $168.8 million, up 516.1% from FY2024.

  • Annual Common Equity shows a five-year compound annual growth rate of -3.9% (FY2020 to FY2025).
  • In prior years, DBV Technologies' Common Equity was $27.4 million in FY2024 (-80.5%), $140.19 million in FY2023 (-27.9%), $194.45 million in FY2022 (+95.9%) and $99.27 million in FY2021 (-51.7%).
  • Quarterly Common Equity has run from a low of $2.9 million in Q1 2025 to a high of $244.42 million in Q2 2022 over five years.
  • On a year-over-year basis, Common Equity increased in three of the last seven quarters, with growth averaging 52.7%.
  • The strongest year-over-year quarter for Common Equity in the past five years was Q4 2025, with growth of 516.1%; the weakest was Q1 2025, with a decline of 97.4%.
  • According to Business Quant data, Common Equity for the three prior quarters was $207.9 million (Q1 2026), $168.8 million (Q4 2025) and $52.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 DBV Technologies 5.05 Bn 4.38 Bn - 160.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 160.40 Mn
Mar 31, 2026 207.90 Mn
Dec 31, 2025 168.80 Mn
Sep 30, 2025 52.85 Mn
Jun 30, 2025 86.20 Mn
Mar 31, 2025 2.90 Mn
Dec 31, 2024 27.40 Mn
Sep 30, 2024 54.03 Mn
Jun 30, 2024 79.10 Mn
Mar 31, 2024 111.65 Mn
Dec 31, 2023 140.19 Mn
Sep 30, 2023 143.99 Mn
Jun 30, 2023 164.24 Mn
Mar 31, 2023 179.09 Mn
Dec 31, 2022 194.45 Mn
Sep 30, 2022 212.05 Mn
Jun 30, 2022 244.42 Mn
Mar 31, 2022 82.06 Mn
Dec 31, 2021 99.27 Mn
Sep 30, 2021 116.89 Mn
API Access

DBV Technologies Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=DBVT&period=max&api_key=YOUR_API_KEY